TFAP4, predominantly recognized as an oncogene (Wong et al., 2021), has recently been implicated in exacerbating liver fibrosis and tissue inflammation in mice by promoting the activation of the STING signaling pathway (Han et al., 2025). Here, TFAP4 is linked to Hepatic fibrosis.